BridgeMD
New treatment option for Blood Cancer
Official title Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)
ClinicalTrials.gov ID: NCT06469307
What this study is testing
- What it's testing
- The purpose of this research study is to enhance inclusion and diversity in clinical trial enrollment by training participants to perform and provide feedback through a community-based protocol review process, called DIVERSE.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- CAB Participant
- Age 18 or older
- English speaking
- Ability to understand and willingness to provide oral consent
- DFCI patient who are in remission from a blood cancer \>1 year will be preferred. CAB Participant
You likely can't join if
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers \<18 years old)
- Prisoners.
- Unwilling/unable to agree to maintaining the confidentiality of reviews and clinical trial materials, as outlined in Section 9.1
- Note 1: Patients and non-patient community members who are pregnant are eligible. This is a non-treatment study that meets the definition of minimal...
- Note 2: English fluency is necessary as protocols being reviewed are written in English and cannot be feasibly translated to other languages within...
See the full eligibility criteria
- CAB Participant
- Age 18 or older
- English speaking
- Ability to understand and willingness to provide oral consent
- DFCI patient who are in remission from a blood cancer \>1 year will be preferred. CAB Participant
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers \<18 years old)
- Prisoners.
- Unwilling/unable to agree to maintaining the confidentiality of reviews and clinical trial materials, as outlined in Section 9.1
- Note 1: Patients and non-patient community members who are pregnant are eligible. This is a non-treatment study that meets the definition of minimal risk and poses no greater risk to pregnant individuals or fetuses...
- Note 2: English fluency is necessary as protocols being reviewed are written in English and cannot be feasibly translated to other languages within the time period necessary to complete timely reviews. Investigator...
- Age 18 older
- English Speaking
- Site or Principal investigator
- Not a member of the research team
The study team makes the final eligibility decision.
Where it's taking place
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boston, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.